Updated on 19 October 2026
ECITD | Horizon Europe Health 2027 – Consortium Partner for Stakeholder Engagement, Policy & Innovation Uptake
Director, Strategy & Institutional Development at Egyptian Center for Innovation and Technology Development (ECITD)
Cairo, Egypt
About
The Egyptian Center for Innovation and Technology Development (ECITD) is an independent Egyptian centre supporting research and innovation, technology transfer, institutional development and international R&I cooperation.
ECITD serves as the secretariat of the Euro-Mediterranean Innovation Ecosystem Board and works to connect research institutions, industry, policymakers and innovation stakeholders across Egypt and the wider Euro-Mediterranean region.
Our Horizon Europe Experience
ECITD has established experience in EU-funded collaborative projects, including:
-
EU-Africa PerMed (GA 964333): Co-leader of WP2 alongside INNOVATEC, contributing to scientific and policy landscape analysis, stakeholder mapping and Europe-Africa cooperation in personalised medicine.
-
FUTURE4PRIMA (GA 101131632): Horizon Europe beneficiary supporting the development of the future Euro-Mediterranean PRIMA partnership.
-
PHEMAC: Consortium partner in Euro-Mediterranean innovation mapping, knowledge capitalisation and stakeholder engagement.
-
INNOVATILE: Egyptian project partner contributing to industrial stakeholder mobilisation and the uptake of sustainable technologies.
What ECITD Can Contribute
We are interested in joining Horizon Europe Health 2027 consortia as a beneficiary and implementation partner, particularly through:
-
Stakeholder identification, mapping and engagement across healthcare, research, industry and public institutions.
-
Health policy analysis, institutional coordination and science-to-policy interfaces.
-
Stakeholder co-design and identification of implementation and adoption barriers.
-
Innovation uptake, knowledge transfer, exploitation and dissemination.
-
Engagement of relevant Egyptian and Euro-Mediterranean institutions to support project implementation and replication.
-
Capacity building, cross-regional knowledge exchange and sustainability planning.
Topic
- Destination 1: HORIZON-HLTH-2027-01-STAYHLTH-01: Addressing disabilities through the life course to support independent living and inclusion
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic non-communicable diseases in children and young people (GACD)
- Destination 4: HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
Type
- Partner seeks Consortium/Coordinator
Attached files
Organisation
Egyptian Center for Innovation and Technology Development (ECITD)
Association/Agency/Cluster
Cairo, Egypt
Similar opportunities
Project cooperation
Ekram Essawi
Deputy director research and innovation at Academy of Scientific research and technology
Cairo, Egypt
Project cooperation
Turning healthcare innovation into real-world impact.
- Consortium/Coordinator seeks Partners
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
- Destination 2: HORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03: Tools and technologies to support health adaptation to climate change
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-06: Development of monoclonal antibodies to prevent and treat infections from Flaviviruses
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-08: Development of innovative antimicrobials against pathogens resistant to antimicrobials
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-14-two-stage: Clinical trials for advancing innovative interventions for neurodegenerative
- Destination 1: HORIZON-HLTH-2027-01-STAYHLTH-01: Addressing disabilities through the life course to support independent living and inclusion
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic non-communicable diseases in children and young people (GACD)
- Destination 4: HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
- Destination 2: HORIZON-HLTH-2027-01-ENVHLTH-02: Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-07: Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses
- Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Anna Lackner
Managing Director at Nexuswelt Group - EU Funding and Innovation Agency
München, Germany
Project cooperation
Horizon Europe Health 2027: Impact, Exploitation and Healthcare Innovation Uptake Partner
- Partner seeks Consortium/Coordinator
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
- Destination 2: HORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03: Tools and technologies to support health adaptation to climate change
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-06: Development of monoclonal antibodies to prevent and treat infections from Flaviviruses
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-08: Development of innovative antimicrobials against pathogens resistant to antimicrobials
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-14-two-stage: Clinical trials for advancing innovative interventions for neurodegenerative
- Destination 1: HORIZON-HLTH-2027-01-STAYHLTH-01: Addressing disabilities through the life course to support independent living and inclusion
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic non-communicable diseases in children and young people (GACD)
- Destination 4: HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
- Destination 2: HORIZON-HLTH-2027-01-ENVHLTH-02: Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-07: Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses
- Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Anna Lackner
Managing Director at Nexuswelt Group - EU Funding and Innovation Agency
München, Germany